Investor's Champion
How to make your money go further

The Ten Bagger Quest - another string to Angle’s bow

21/03/2016 · Angle Plc (AGL) 

​Significant progress with prostate cancer
By Michael Crockett

There was exciting news from Angle today. Bart’s Cancer Institute has provided evidence in support of Angle’s Parsortix system being used for the detection and assessment of prostate cancer.

Angle has gained many supporters from key cancer specialists worldwide in recent months. Its liquid biopsy technology has been shown to be effective with a number of cancers. A clinical trial is already ongoing to assess Parsortix’s effectiveness on Ovarian cancer and today’s news could lead to a very large clinical application with prostate cancer, the second most common cancer in men worldwide.

The Ten Bagger Quest
A number of the companies featured in AimZine’s Ten Bagger Quest articles are now making excellent progress; most notably Surface Transforms and Software Radio Technology. We have recently identified some further small companies which have exciting ten bagger potential and will be publishing further AimZine Ten Bagger articles in the near future.

Angle (AIM: AGL) http://www.angleplc.com/ Introduction Investor’s Champion highlighted the potential of Angle in this July 2013 AimZine Ten Bagger Quest article. Since that time Angle has made considerable progress in trials with a number of collaborators - see the impressive list at http://www.angleplc.com/the-company/collaborators/. Angle’s Parsortix system has already been demonstrated with ovarian, prostate, breast, lung, colorectal, pancreatic and renal cancers. To date the most advanced work is in connection with ovarian cancer where clinical studies with three major European cancer centres are planned. Angle is also pursuing its first US FDA approval for Parsortix for use in breast cancer. Clinical…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login

Investor’s Champion, making your money go further.

ABOUT INVESTORS CHAMPION

Investor's Champion offers objective, incisive and forthright comment on quoted companies and personal finance. Our content addresses what we believe are the key issues in helping make your money go further.

Investor's Champion is a registered trade mark of Investors Champion Ltd. Investor's Champion Limited is a company registered in England and Wales under number 03577867 whose registered office is at Fourth & Fifth Floor, 14-15 Lower Grosvenor Place, London, England, SW1W 0EX.

All rights reserved. © 2007 - 2024